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INTRODUCTION 
 Doppler ultrasonography (US) has enabled the noninvasive 
investigation of hepatic and portal hemodynamics. Thus, many 
investigators have attempted to assess portal hypertension with Doppler 
US in patients with cirrhosis. In particular, any Doppler technique that 
could be a suitable substitute for the invasive assessment of portal 
hypertension, such as measurement of the hepatic venous pressure 
gradient (HVPG), would be highly desirable.   
 However, at present, both the clinical usefulness and the value of 
Doppler US in the assessment of portal hypertension remain unsettled. 
Doppler indices that have been commonly used for evaluation of portal 
hypertension include the measurement of portal and splenic venous 
blood flow velocity and resistive index of splenic, hepatic, and superior 
mesenteric arteries. However, these indices are plagued by a lack of 
reproducibility and accuracy due to intra- and interobserver variability 
and interequipment variability.  
 - 2 -
 The Doppler waveform of the hepatic vein in healthy subjects is 
normally triphasic (two negative waves and one positive wave) because 
of  central venous pressure variations due to the cardiac cycle . It has 
been established that the normal triphasic hepatic vein waveform is 
transformed into a biphasic or monophasic waveform in patients with 
cirrhosis. Moreover, a monophasic waveform has been shown to 
correlate with a high Child-Pugh score and a poor survival rate.  
 Thus, it would be reasonable to hypothesize that abnormalities in 
the hepatic vein waveform are related to the degree of portal 
hypertension. To our knowledge, one study has been performed to 
examine a possible correlation between abnormalities in the hepatic vein 
waveform and the severity of portal hypertension in patients with 
cirrhosis. Thus, the purpose of our study was to prospectively evaluate 
hepatic vein Doppler waveforms and the response to drug treatment in 
patients with cirrhosis.  
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AIM 
[ 
1.  To prospectively evaluate Doppler ultrasonography hepatic vein 
waveform patterns in patients with portal hypertension and 
variceal bleeding. 
2. To monitor the response to drug treatment (propranolol) in those 
patients.  
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REVIEW OF LITERATURE 
     Analysis  of  hepatic  vein  waveform  by  Doppler ultrasonography   
in 100 patients with portal hypertension was done by   
Ohta M et al.1  He classified the Doppler waveform seen in patients 
with portal hypertension and examined the associations of the waveform 
type with the diagnosis of Budd-Chiari syndrome and severity of the 
liver cirrhosis. The Doppler pattern of right and left hepatic veins in 100 
consecutive Japanese patients with portal hypertension and 
esophagogastric varices was classified into six types. Their classification 
of hepatic vein waveform in Doppler ultrasonography is useful in 
diagnosing Budd-Chiari syndrome, in judging the efficiency of 
treatment for hepatic vein lesions, and in assessing severe liver function 
in cirrhotic patients. 
    Kemal Arda et al.2 studied 30 patients who had been diagnosed 
with chronic liver disease (Child-Pugh class A) and 30 healthy subjects. 
The diagnosis was confirmed with histopathologic examinations of 
biopsy specimens in 17 patients. He concluded that there was a 
significant difference (p < 0.05) between the control group and the 
patient group with respect to the presence of abnormal (type I + type II) 
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Doppler waveform. The diagnostic accuracy in the patients who had 
biopsy was 76.47% and that in the patients who did not was 69.23%. 
 Nevzat Karabulut et al.3 Observed that there was an inverse 
correlation between the sonographic grade of the hepatosteatosis and the 
phasicity of hepatic venous flow (r=–0.67, P<0.001). And concluded 
that the hepatic vein pulsatility is significantly dampened in obese 
patients correlating with the grade of hepatosteatosis. The body habitus 
itself does not have an independent effect on hepatic venous waveform. 
The alteration in hepatic vein Doppler flow pattern in an obese 
population may suggest reduced vascular compliance in the liver 
because of fatty infiltration. 
 Levent Oguzkurt et al.4 studied 40 patients with diffuse FIL and 
50 normal healthy adults who served as control group underwent hepatic 
vein (HV) Doppler ultrasonography. And concluded that Patients with 
fatty liver has a high rate of an abnormal hepatic vein Doppler 
waveform pattern which can be biphasic or monophasic. They could not 
find a relation between the etiological factors for FIL and the occurrence 
of an abnormal HV Doppler waveform.  
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 S. Jequier et al.5 In his study concluded that not all healthy 
children have a triphasic flow pattern in all hepatic veins. Before 
suspecting hepatic abnormality with abnormal parenchymal compliance 
(cirrhosis, graft rejection) by virtue of lack of triphasic hepatic vein flow, 
a normal variant of the flow should be considered. Only the change of a 
previously documented triphasic flow to monophasic flow in a given 
vein should be assessed as a sign of possible abnormality.  
 Hashizume M. et al.6 prospectively evaluated the prognostic 
value of the flat hepatic vein waveform, measured by Doppler 
ultrasound, in cirrhotic patients with portal hypertension. And concluded 
the prognostic accuracy in cases of cirrhosis with portal hypertension is 
significantly improved with acquistion of information obtained from 
hepatic vein waveform by Doppler ultrasound. 
 W Gorka et al.7 in his study he concluded that Simple 
recognition of patterns seen in hepatic vein waveform morphology in 
patients with liver cirrhosis caused by hepatitis C is superior to portal 
Doppler flowmetry for predicting the size of esophageal varices. 
 H. Sugimoto et al.8 in his study to recognize “normal” hepatic 
hemodynamics after live donor liver transplantation (LDLT), he 
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analyzed Doppler parameters on recipients with a right liver graft and 
donors after extended left hepatectomy. Theoretically these values 
should be the same. From April 2000 to October 2004, 20 LDLTs were 
performed using a right liver graft. The 10 recipients without 
postoperative complications and their donors were included in this study. 
Portal venous velocity (PVV; cm/s), hepatic arterial peak systolic 
velocity (cm/s), and hepatic venous peak velocity (HVPV; cm/s) were 
measured during the first 2 weeks. In donors PVV and HVPV after 
LDLT were significantly higher after than before left hepatectomy. And 
he concluded that “abnormal” hepatic hemodynamics in even those 
recipients without complications during the early postoperative period 
after LDLT. 
 Soon Koo Baik et al.9 prospectively evaluated both the 
correlation between abnormal Doppler ultrasonography (US) hepatic 
vein waveforms and the hepatic venous pressure gradient (HVPG) and 
the response to drug treatment in patients with cirrhosis. And he 
concluded that Doppler US hepatic vein waveform assessment is useful 
in the noninvasive evaluation of the severity of portal hypertension and 
the response to vasoactive drugs in patients with portal hypertension and 
variceal bleeding.  
 - 8 -
 
 Moon Young Kim et al.10  prospectively evaluated the 
correlation between the extent of abnormal Doppler HV waveforms 
expressed as damping index (DI) and the hepatic venous pressure 
gradient (HVPG) and response to propranolol in patients with cirrhosis.  
And he concluded that Damping index of the HV waveform by Doppler 
ultrasonography might be a non-invasive supplementary tool in 
evaluating the severity of portal hypertension and in responding to 
propranolol in patients with liver cirrhosis. 
 J F Pedersen et al.11 examined the frequency of absent retrograde 
flow in a consecutive series of 139 patients referred for abdominal 
ultrasound. He used state-of-theart ultrasound scanners, and placed the 
Doppler gate so that in non-forced end-expiration it would sample the 
right hepatic vein 4–6 cm from the vena cava. There was no association 
between the hepatic vein flow pattern and age, sex or body mass index. 
43 of 139 studied patients showed absent retrograde flow. Review of the 
case records revealed liver disease in 26 patients and no sign of liver 
disease in 17 patients. He Concluded that absent retrograde flow in the 
hepatic veins may be seen not only in patients with overt liver disease 
but also in apparently liver-healthy patients. 
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 KC Sudhamshu et al.12 in his study Hepatic vein waveforms 
were classifi ed into three classical patterns. Flat waveform was 
uncommon. Mean hepatic vein velocity was significantly higher in 
cirrhotic patients (12.7 ± 6.4 vs 5.1 ± 2.1 and 6.2 ± 3.2 cm/s; P < 
0.0001). The poorer the grade of cirrhosis, the higher was the mean 
velocity. Maximum forward velocity was never greater than 40 cm/s in 
controls. Degree of ascites was found to be highly correlated with mean 
velocity. “Very high” group (≥ 20 cm/s) presented clinically with 
moderate to massive ascites. Correlations between right portal flow and 
mean velocity was signifi cant ( P < 0.0001, r = 0.687)..  And he 
concluded that Doppler waveforms of hepatic vein, which is 
independent of liver dysfunction, should be obtained during normal 
respiration. Mean hepatic vein velocity reflects the change in hepatic 
circulation associated with progression of liver cirrhosis. It can be used 
as a new parameter in the assessment of liver cirrhosis. 
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PORTAL HYPERTENSION 
 The portal system includes all the veins which drain the blood 
from the abdominal part of the digestive tube (with the exception of the 
lower part of the rectum) and from the spleen, pancreas, and  
gall-bladder. From these viscera the blood is conveyed to the liver by 
the portal vein. In the liver this vein ramifies like an artery and ends in 
capillary-like vessels termed sinusoids, from which the blood is 
conveyed to the inferior vena cava by the hepatic veins.  
 From this it will be seen that the blood of the portal system passes 
through two sets of minute vessels, viz., (a) the capillaries of the 
digestive tube, spleen, pancreas, and gall-bladder; and (b) the sinusoids 
of the liver. In the adult the portal vein and its tributaries are destitute of 
valves; in the fetus and for a short time 
after birth valves can be demonstrated 
in the tributaries of the portal vein; as 
a rule they soon atrophy and disappear, 
but in some subjects they persist in a 
degenerate form.    
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 The portal vein (vena portæ) is about 8 cm. in length, and is 
formed at the level of the second lumbar vertebra by the junction of the 
superior mesenteric and lienal veins, the union of these veins taking 
place in front of the inferior vena cava and behind the neck of the 
pancreas. It passes upward behind the superior part of the duodenum and 
then ascends in the right border of the lesser omentum to the right 
extremity of the porta hepatis, where it divides into a right and a left 
branch, which accompany the corresponding branches of the hepatic 
artery into the substance of the liver.  
 In the lesser omentum it is placed behind and between the 
common bile duct and the hepatic artery, the former lying to the right of 
the latter. It is surrounded by the hepatic plexus of nerves, and is 
accompanied by numerous lymphatic vessels and some lymph glands. 
The right branch of the portal vein enters 
the right lobe of the liver, but before doing 
so generally receives the cystic vein. The 
left branch, longer but of smaller caliber 
than the right, crosses the left sagittal fossa, 
gives branches to the caudate lobe, and 
then enters the left lobe of the liver. As it 
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crosses the left sagittal fossa it is joined in front by a fibrous cord, the 
ligamentum teres (obliterated umbilical vein), and is united to the 
inferior vena cava by a second fibrous cord, the ligamentum venosum. 
The tributaries of the portal vein are:    
 Lienal.Pyloric. Superior Mesenteric. Cystic. Coronary. 
Parumbilical.  The Lienal Vein (v. lienalis; splenic vein) commences by 
five or six large branches which return the blood from the spleen. These 
unite to form a single vessel, which passes from left to right, grooving 
the upper and back part of the pancreas, below the lineal artery, and 
ends behind the neck of the pancreas by uniting at a right angle with the 
superior mesenteric to form the portal vein. The splenic vein is of large 
size, but is not tortuous like the artery.    
 The splenic vein receives the short gastric veins, the left 
gastroepiploic vein, the pancreatic veins, and the inferior mesenteric 
veins.    
 The short gastric veins (vv. gastricæ breves), four or five in 
number, drain the fundus and left part of the greater curvature of the 
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stomach, and pass between the two layers of the gastrolienal ligament to 
end in the splenic vein or in one of its large tributaries.    
 The left gastroepiploic vein (v. gastroepiploica sinistra) receives 
branches from the antero-superior and postero-inferior surfaces of the 
stomach and from the greater omentum; it runs from right to left along 
the greater curvature of the stomach and ends in the commencement of 
the splenic vein.    
 The pancreatic veins (vv. pancreaticæ) consist of several small 
vessels which drain the body and tail of the pancreas, and open into the 
trunk of the splenic vein.    
 The inferior mesenteric vein (v. mesenterica inferior) returns 
blood from the rectum and the sigmoid, and descending parts of the 
colon. It begins in the rectum as the superior hemorrhoidal vein, which 
has its origin in the hemorrhoidal plexus, and through this plexus 
communicates with the middle and inferior hemorrhoidal veins. The 
superior hemorrhoidal vein leaves the lesser pelvis and crosses the left 
common iliac vessels with the superior hemorrhoidal artery, and is 
continued upward as the inferior mesenteric vein. This vein lies to the 
left of its artery, and ascends behind the peritoneum and in front of the 
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left Psoas major; it then passes behind the body of the pancreas and 
opens into the splenic vein; sometimes it ends in the angle of union of 
the splenic and superior mesenteric veins.    
 The inferior mesenteric vein receives the sigmoid veins from the 
sigmoid colon and iliac colon, and the left colic vein from the 
descending colon and left colic flexure.    
 The Superior Mesenteric Vein (v. mesenterica superior) returns 
the blood from the small intestine, from the cecum, and from the 
ascending and transverse portions of the colon. It begins in the right iliac 
fossa by the union of the veins which drain the terminal part of the ileum, 
the cecum, and vermiform process, and ascends between the two layers 
of the mesentery on the right side of the superior mesenteric artery. In its 
upward course it passes in front of the right ureter, the inferior vena cava, 
the inferior part of the duodenum, and the lower portion of the head of 
the pancreas. Behind the neck of the pancreas it unites with the splenic 
vein to form the portal vein.    
 Besides the tributaries which correspond with the branches of the 
superior mesenteric artery, viz., the intestinal, ileocolic, right colic, and 
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middle colic veins, the superior mesenteric vein is joined by the right 
gastroepiploic and pancreaticoduodenal veins.    
 The right gastroepiploic vein (v. gastroepiploica dextra) receives 
branches from the greater omentum and from the lower parts of the 
antero-superior and posteroinferior surfaces of the stomach; it runs from 
left to right along the greater curvature of the stomach between the two 
layers of the greater omentum.    
 The pancreaticoduodenal veins (vv. pancreaticoduodenales) 
accompany their corresponding arteries; the lower of the two frequently 
joins the right gastroepiploic vein.    
 The Coronary Vein (v. coronaria ventriculi; gastric vein) derives 
tributaries from both surfaces of the stomach; it runs from right to left 
along the lesser curvature of the stomach, between the two layers of the 
lesser omentum, to the esophageal opening of the stomach, where it 
receives some esophageal veins. It then turns backward and passes from 
left to right behind the omental bursa and ends in the portal vein.    
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     The Pyloric Vein is of small size, and runs from left to right along the 
pyloric portion of the lesser curvature of the stomach, between the two 
layers of the lesser omentum, to end in the portal vein.    
 The Cystic Vein (v. cystica) drains the blood from the  
gall-bladder, and, accompanying the cystic duct, usually ends in the 
right branch of the portal vein.    
 Parumbilical Veins (vv. parumbilicales).—In the course of the 
ligamentum teres of the liver and of the middle umbilical ligament, 
small veins (parumbilical) are found which establish an anastomosis 
between the veins of the anterior abdominal wall and the portal, 
hypogastric, and iliac veins. The best marked of these small veins is one 
which commences at the umbilicus and runs backward and upward in, or 
on the surface of, the ligamentum 
teres between the layers of the 
falciform ligament to end in the 
left portal vein.    
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     Collateral venous circulation 
to relieve portal obstruction in the 
liver may be effected by 
communications between (a) the 
gastric veins and the esophageal 
veins which often project as a 
varicose bunch into the stomach, 
emptying themselves into the hemiazygos vein; (b) the veins of the 
colon and duodenum and the left renal vein; (c) the accessory portal 
system of Sappey, branches of which pass in the round and falciform 
ligaments (particularly the latter) to unite with the epigastric and internal 
mammary veins, and through the diaphragmatic veins with the azygos; a 
single large vein, shown to be a parumbilical vein, may pass from the 
hilus of the liver by the round ligament to the umbilicus, producing there 
a bunch of prominent varicose veins known as the caput medusæ; (d) the 
veins of Retzius, which connect the intestinal veins with the inferior 
vena cava and its retroperitoneal branches; (e) the inferior mesenteric 
veins, and the hemorrhoidal veins that open into the hypogastrics; (f) 
very rarely the ductus venosus remains patent, affording a direct 
connection between the portal vein and the inferior vena cava. 
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     The Hepatic Veins (vv. hepaticæ) commence in the substance of the 
liver, in the terminations of the portal vein and hepatic artery, and are 
arranged in two groups, upper and lower. The upper group usually 
consists of three large veins, which converge toward the posterior 
surface of the liver, and open into the inferior vena cava, while that 
vessel is situated in the groove on the back part of the liver. The veins of 
the lower group vary in number, and are of small size; they come from 
the right and caudate lobes. The hepatic veins run singly, and are in 
direct contact with the hepatic tissue. They are destitute of valves.  
     The portal vein drains blood 
from the small and large intestines, 
stomach, spleen, pancreas, and 
gallbladder. The superior 
mesenteric vein and the splenic 
vein unite behind the neck of the 
pancreas to form the portal vein. The portal trunk divides into 2 lobar 
veins. The right branch drains the cystic vein, and the left branch 
receives the umbilical and paraumbilical veins that enlarge to form 
umbilical varices in portal hypertension. The coronary vein, which runs 
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along the lesser curvature of the stomach, receives distal esophageal 
veins, which also enlarge in portal hypertension. 
 Portal hypertension may be defined as a portal pressure gradient 
of 12 mm Hg or greater and is often associated with varices and ascites. 
Many conditions are associated with portal hypertension, of which 
cirrhosis is the most common cause. 
Causes:  
Causes of increased resistance to flow are described as 
follows:  
1. Prehepatic 
o Portal vein thrombosis  
o Splenic vein thrombosis  
o Congenital atresia or stenosis of portal vein  
o Extrinsic compression (tumors)  
o Splanchnic arteriovenous fistula 
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2. Intrahepatic, 
 
a) Predominantly Presinusoidal 
o Schistosomiasis (early stage) 
o Primary biliary cirrhosis (early stage) 
o Idiopathic portal hypertension (early stage) 
o Nodular regenerative hyperplasia: Pathogenesis probably is 
obliterative venopathy. The presence of nodules that press 
on the portal system also has been postulated to play a role, 
although nodularity is present in most cases without clinical 
evidence of portal hypertension. 
o Myeloproliferative diseases: These act by direct infiltration 
by malignant cells. 
o Polycystic disease 
o Hepatic metastasis 
o Granulomatous diseases (sarcoidosis, tuberculosis): 
Clinical liver dysfunction is rare in sarcoidosis. Portal 
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hypertension is an unusual, although well-recognized 
manifestation of hepatic sarcoidosis. Sarcoid granulomas 
frequently localize in the portal areas, resulting in injury to 
the portal veins. 
b) Predominantly Sinusoidal And/Or Postsinusoidal 
o Hepatic cirrhosis  
o Acute alcoholic hepatitis  
o Schistosomiasis (advanced stage)  
o Primary biliary cirrhosis (advanced stage)  
o Idiopathic portal hypertension (advanced stage)  
o Acute and fulminant hepatitis  
o Congenital hepatic fibrosis  
o Vitamin A toxicity: Noncirrhotic portal fibrosis is observed 
with various toxic injuries, and one of these includes 
vitamin A toxicity. This probably is due to vascular injury. 
Excessive doses of vitamin A taken for months or years can 
lead to chronic hepatic disease. Intake of doses ranging 
from as small as 3-fold the recommended daily dose 
continued for years to doses as high as 20-fold the 
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approved dose in a few months can lead to hepatic disease. 
The pericellular fibrosis characteristic of vitamin A toxicity 
may lead to portal hypertension.  
o Peliosis hepatitis  
o Venoocclusive disease  
o Budd-Chiari syndrome 
3. Posthepatic 
o Inferior vena cava (IVC) obstruction  
o Right heart failure  
o Constrictive pericarditis  
o Tricuspid regurgitation 
o Budd-Chiari syndrome 
o Arterial-portal venous fistula 
o Increased portal blood flow 
o Increased splenic flow 
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Hemodynamic Measurement Of Portal Pressure : 
 Direct portal measurements usually are not performed due to the 
invasive nature, the risk of complications, and the interference of 
anesthetic agents on portal hemodynamics. The most commonly used 
method is measurement of the hepatic venous pressure gradient (HVPG), 
which is an indirect measurement that closely approximates portal 
venous pressure. 
 A fluid-filled balloon catheter is introduced into the femoral or 
internal jugular vein and advanced under fluoroscopy into a branch of 
the hepatic vein. Free hepatic venous pressure (FHVP) then is measured. 
     The balloon is inflated until it is 
wedged inside the hepatic vein, 
occluding it completely, thus equalizing 
the pressure throughout the static 
column of blood. The occluded hepatic 
venous pressure (ie, wedged hepatic 
venous pressure) minus the unoccluded, or free, portal venous pressure 
(ie, FHVP) is the HVPG. 
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Duplex-Doppler Ultrasonography : 
 Ultrasound (US) is a safe, economical, and effective method for 
screening for portal hypertension. It also can demonstrate portal flow 
and helps in diagnosing cavernous transformation of the portal vein, 
portal vein thrombosis, or splenic vein thrombosis. 
  
 
 
 
 Features suggestive of hepatic cirrhosis with portal hypertension 
include the following :  
o Nodular liver surface is suggestive. However, this finding is not 
specific for cirrhosis and can be observed with congenital hepatic 
fibrosis and nodular regenerative hyperplasia.  
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o Splenomegaly is a suggestive finding.  
o Patients may demonstrate the presence of collateral circulation. 
 
 
 
 
 
Limitations of US include the following :  
o Reproducibility of data is problematic.  
o Many variables, such as circadian rhythm, meals, medications, 
and the sympathetic nervous system, affect portal hemodynamics.  
o Significant interobserver and intraobserver variation exist in 
quantitative ultrasonographic measurement 
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Patient Preparation & Positioning 
• The abdominal Doppler examination is explained to the patient 
and any questions are answered.  
• A history is obtained from the patient focusing on risk factors, 
signs, and symptoms of hepatocellular disease. Previous medical 
history relating to hepatocellular disease should be noted.  
• Any recent surgical intervention of shunt placement within the 
portal venous system is documented in the patient history work 
sheet.  
• The patient is placed initially in the supine position; the patient 
may be rolled into a slight left lateral decubitus position to obtain 
a better intercostal window. The images and Doppler evaluation 
may be obtained in the longitudinal, coronal, oblique, or 
transverse planes.  
• Breath holding is very important in obtaining good Doppler color 
and spectral waveforms. Initially scan the patient in shallow 
respiration to set up your controls and depth. Then instruct the 
patient to stop breathing when you obtain the Doppler images. 
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Techniques 
General Technical Points  
• Place ultrasound gel on the abdomen to ensure good transducer-
to-skin contact during the abdominal Doppler imaging 
examination.  
• The transducer's orientation marker should be pointing toward the 
patient's right side during the examination when a transverse scan 
is performed; the orientation marker is directed toward the 
patient's head when a longitudinal scan is performed.  
• The examination is performed with both gray scale and Doppler 
evaluation of the portal venous system, the hepatic veins, and 
hepatic arteries.  
• Remember, the transducer must be PARALLEL to the vessel; the 
Doppler angle should be less than sixty degrees to obtain the 
maximum peak systolic velocity. At the end of the examination, 
the ultrasound gel should be removed from the patient and any 
excess gel should be removed from the transducer. The transducer 
should be cleaned using a disinfectant. 
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Doppler  
• The evaluation of the portal venous system, hepatic veins, and 
hepatic artery is performed during the Doppler imaging 
examination.  
• Doppler signals or color Doppler imaging should be obtained 
from the imaging plane that allows the beam to be as parallel to 
the vessel as possible.  
• A liver Doppler should also evaluate flow in the extra-hepatic 
portal venous system, and IVC. These images should be obtained 
prior to the PW evaluation.  
• Also document the size of the CBD, liver, kidneys, and spleen.  
• Look in the pelvic cavity and lower quadrants for the presence of 
free fluid. 
Doppler Technique  
• The pulse repetition frequency (PRF) allows one to record lower 
velocities as the PRF is lowered; as the PRF is increased, the 
lower velocities are filtered out to record only the higher velocity 
signal.  
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• The PRF may be changed with the scale control on the Doppler 
panel (look at the color bar on the left side of the monitor, the 
PRF will change as the "scale" on the Doppler control is changed.  
• The PRF increases as imaging depth increases and decreases as 
depth decreases. Flow within the normal hepatic venous system is 
low; therefore a lower PRF is necessary to record the flow pattern. 
As the flow increases beyond 40 cm/sec, the PRF should be 
increased to prevent aliasing. (Aliasing may also be reduced by 
scanning at a lower frequency).  
• The Doppler sample volume should be smaller than the diameter 
of the lumen. If you have difficulty finding the vessel, increase 
the width of the sample volume to locate the flow, and then 
reduce the volume width to clean up the spectral waveform.  
• The Doppler angle correction should be less than 60 degrees to 
display the peak spectral velocity.  
• Wall filters help to eliminate "noise" or low level Doppler shifts 
seen within the vessel. 
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Doppler Observations 
Hepatic Artery  
• Low resistance waveform; forward flow in diastole above 
baseline  
• Vessel is tortuous; flow may appear to move toward and away 
from the transducer.  
• Systolic window with narrow bandwidth with parabolic flow 
profile  
• Spectral fill-in of systolic window due to small vessel diameter  
• High resistance waveforms may indicate veno-occlusive disease 
Portal Venous System  
• Continuous low velocity phasic signal; phasic means that the 
velocity increases and decreases with respirations giving the 
signal a smooth wavelike appearance  
• Normal flow is termed hepatopedal (toward the liver)  
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• Reversed flow is hepatofugal.  
• Portal venous thrombosis or post op anastomosis from a liver 
transplant can cause an abnormal portal vein signal: results from 
decreased vessel lumen size which reduces the pressure, and 
consequently increases the velocity of flow through the narrowed 
region - "choppy" appearance as result of increased velocities.  
NOTE: The hepatic artery and portal vein flow should be in the same 
direction as the hepatic artery runs parallel with the portal vein. 
Hepatic Venous System  
• Multi-phasic pulsatile flow pattern secondary to proximity of the 
right atrium with flow above and below the baseline due to close 
proximity to the right atrium which results in hemodynamic 
changes  
• Right sided heart failure may cause the hepatic veins to become 
pulsatile and dilated.  
• Increased intrahepatic pressure or venous obstruction 
demonstrates a more continuous or monophasic signal 
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Inferior Vena Cava  
• Continuous waveform with respiratory variations; become more 
pulsatile as it empties into the right atrium.  
• Best imaged with a slight cranial-caudal sweep in the longitudinal 
plane with the patient in deep inspiration  
• Anastomosis from surgical transplantation may alter the normal 
flow into the IVC  
• Thrombosis can cause the IVC waveform to appear monophasic 
with high velocities ("choppy" appearance). Evaluate for 
thrombus in the renal veins as well.  
• If a surgical shunt is present, be sure to check the patient's history 
to find out the specific type of shunt (portal/cava or 
mesenteric/cava) is in place. 
Duplex Imaging Technique 
Terminology: 
• Left hepatic vein - LHV  
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• Left hepatic artery - LHA  
• Left portal vein - LPV  
• Right hepatic vein - RHV  
• Right hepatic artery - RHA  
• Right portal vein - RPV  
• Common (main) hepatic artery - CHA  
• Main portal vein - MPV  
• Middle hepatic vein - MHV 
The hepatic vessels should be imaged at four anatomical locations: 
• Midline, beneath the xyphoid for the LHV, LHA, and LPV;  
• Mid-clavicular and intercostal at the portal hepatis for the MHA 
and MPV;  
• Lateral and intercostal at the right lobe for the RHA and RPV;  
• Subcostal and midclavicular for the RHV and MHV.  
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Primary Prophylaxis :  
     Primary prophylaxis is administered to patients at high risk of 
bleeding. These patients have large varices, red wale markings on the 
varices, and severe liver failure. 
Beta-Blockers : 
     Beta-blockers include propranolol and nadolol. They are used 
most commonly. Beta-blockers are noncardioselective and reduce portal 
and collateral blood flow. Reduction in cardiac output (blockade of 
beta1-adrenoreceptors) occurs. Splanchnic vasoconstriction (blockade of 
vasodilatory adrenoreceptors of the splanchnic circulation) also occurs.  
 A recent meta-analysis of 11 trials evaluating nonselective beta-
blockers in the prevention of first variceal bleeding shows that the 
bleeding rate in controls (25%) is significantly reduced (to 15%) in 
patients treated with beta-blockers after a median follow-up of 24 
months. The mortality rate also is lower in the beta-blocker group; 
however, the difference does not achieve statistical significance. The 
effect of beta-blockers as a function of variceal size also is analyzed. 
The risk of first variceal bleeding in patients with medium-to-large 
varices is 30% in controls, which is significantly reduced to 14% in 
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patients treated with beta-blockers. In patients with small varices, a 
tendency exists for reduction in the first bleeding episode; however, the 
number of patients and the rate of first bleeding are too low to achieve 
statistical significance.  
 Propranolol is administered at a dose of 20 mg every 12 h, which 
is increased or decreased every 3-4 days until a 25% reduction in the 
resting heart rate occurs or the heart rate is down to 55 beats per minute 
(bpm). The average dose of propranolol usually is 40 mg bid. 
Administering more than 320 mg/d is not recommended. Nadolol dosing 
is half the daily dose of propranolol, administered once a day.  
 Response to treatment is monitored by a reduction of the portal 
pressure gradient by more than 20% of the baseline value or less than 12 
mm Hg. Checking the HVPG response in primary prophylaxis is not 
mandatory because 60% of patients who do not achieve these targets do 
not bleed at 2-year follow-up evaluations.  
 Propranolol is contraindicated in patients with asthma, chronic 
obstructive pulmonary disease (COPD), atrioventricular (AV) block, 
intermittent claudication, and psychosis. The most frequent adverse 
effects are light-headedness, fatigue, dyspnea upon exertion, 
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bronchospasm, insomnia, impotence, and apathy. Reducing the dose of 
propranolol frequently controls these adverse effects.  
 Beta-blockers are best continued for the patient's lifetime because 
the risk of variceal hemorrhage returns to that of the untreated 
population once beta-blockers are withdrawn.  
 Soon Koo Baik et al.9 prospectively evaluated both the 
correlation between abnormal Doppler ultrasonography (US) hepatic 
vein waveforms and the hepatic venous pressure gradient (HVPG) and 
the response to drug treatment in patients with cirrhosis. And he 
concluded that Doppler US hepatic vein waveform assessment is useful 
in the noninvasive evaluation of the severity of portal hypertension and 
the response to vasoactive drugs (Terlipressin)in patients with portal 
hypertension and variceal bleeding.  
 
 
 
       HV wave form      HV wave form  
     before terlipressin            after terlipressin 
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Matreials And Methods 
 A prospective study of 60 patients with portal hypertension and  
Variceal bleeding was done in the Barnard Institute of Radiology. 
INCLUSION CRITERIA : 
 All the patients with portal hypertension and recent variceal 
bleeding. 
EXCLUSION CRITERIA : 
All the patients with  
1. Hepato cellular carcinoma 
2. Hepatic encephalopathy 
3. Thrombosis in IVC, hepatic vein or portal vein 
4. Congestive heart failure. 
          Patients with portal hypertension and variceal bleeding were 
included in this study. There were no limitations to the study with 
respective age and sex. All the patients were started with oral 
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propranolol after the initial Doppler ultrasonography. The treatment 
response was studied with hepatic venous waveform. The patients were 
evaluated using Doppler ultrasound with a 3.5MHz curvilinear 
transducer.(ALOKA-3500). The study was done by a single observer 
and thus inter observer variation was eliminated. 
 Doppler traces were obtained in the right or middle hepatic vein at 
a distance of 3 to 6cms from the junction of the hepatic vein and inferior 
vena cava. The 3.5MHz curvilinear probe was placed right lateral 
intercostals approach. Hepatic vein Doppler wave forms were recorded 
for atleast 5 seconds with end expiration breath holding.  
 In colour Doppler flow mapping, a blue hepatic vein waveform 
indicates flow away from the probe. Where as a red portal vein 
waveform indicates flow towards the probe. The hepatic vein 
waveforms are classified as triphasic (reversed flow in atleast one phase), 
biphasic (no reversed flow) or monophasic (flat and with or without 
fluttering).  
 Waveform classification depended on the prescence or absence of 
phasic oscillation. Monophasic waveform is defined as complete loss of 
normal phasic oscillation. 
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RESULTS AND OBSERVATIONS 
 No. of Patients  - 60 
 Male Patients  - 39 
 Female Patients  - 21 
 Male Prepondrance is due to Alcoholic Liver Disease. The 
baseline examination shows Triphasic Hepatic Venous waveforms in 18 
patients, Biphasic waveforms in 30 patients and Monophasic waveforms 
in 12 patients.  
     All the patients were given Propranolol (PPNL). And followup 
Hepatic venous waveform taken every 15 days. No patients showed 
improvement in 15 days. Most of the patients showed improvement in  
1 Month.  
     Thirty Nine Out of Forty Two Patients showed improvement in the 
Hepatic venous waveform. And this correlates with the clinical 
improvement. ie 92.8% patients showed improvement after PPNL both 
clinically and Dopplerwise. 
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Patients Distribution - Sexwise 
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Patients Distribution - Agewise 
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Patients Distribution – Age & Sexwise 
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Clinical Diagnosis Distribution 
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Clinical Diagnosis Distribution - Sexwise 
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Clinical Diagnosis Distribution - Agewise 
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Hepaticvein Waveform – Before PPNL 
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Hepaticvein Waveform – After PPNL 
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Hepaticvein Waveform – Before & After PPNL 
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Response to PPNL 
Response 
to PPNL 
No. of Patients Percentage 
Yes ( + ) 42 93% 
No ( - )  3 7% 
Total 45  
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DISCUSSION 
     The hepatic vein Doppler waveform in healthy humans is triphasic 
because of central venous pressure variations that are due to the cardiac 
cycle. In patients with cirrhosis, other studies have incontrovertibly 
demonstrated the presence of abnormal biphasic or monophasic hepatic 
vein waveforms. In addition, a previous study showed that the 
monophasic waveform was correlated with higher Child-Pugh scores 
and a decreased survival rate.  
     However, little is known about the relationship between hepatic vein 
Doppler waveform abnormalities and portal hypertension. In one study, 
a correlation was found between abnormalities in the hepatic vein 
waveform and the HVPG (ie, as HVPG increased, the hepatic vein 
waveform tended to flatten). Furthermore, the monophasic waveform 
was associated with severe portal hypertension with relatively high 
sensitivity and specificity in that study population. Hence, flattening of 
the hepatic vein waveform in patients with cirrhosis indicates a high 
likelihood of severe portal hypertension. 
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     Some investigators have suggested classifying the hepatic vein 
waveform into six subtypes. In our experience, however, we have found 
that the availability of this many subtypes leads to greater complexity 
and larger inter- and intraobserver variability when assigning a subtype 
to a particular hepatic vein waveform. We believe that the disadvantages 
associated with the availability of more subtypes outweigh the 
advantage of a slight improvement in discriminatory ability. Thus, we 
used a simpler system that we believed was more clinically useful and 
that had only three subtypes.   
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     Sixty patients clinically diagnosed as Portal Hypertension, Alcoholic 
Liver Disease, EHPVO, DCLD and Viral Hepatitis referred for portal 
Doppler. 
     In those patients 21 were Female (35%) and 39 were Male (65%) 
There was no age limit.  Baseline Doppler Ultra sonography was done 
and the Hepatic venous waveform was recorded.  All the patients were 
given Propranolol (PPNL).  And followup studies were done fortnightly.  
The response to PPNL was recorded.  
     The baseline examination shows Triphasic Hepatic Venous 
waveforms in 18 patients, Biphasic waveforms in 30 patients and 
Monophasic waveforms in 12 patients.  
     Kemal Arda et al. studied 30 patients who had been diagnosed with 
chronic liver disease (Child-Pugh class A) and 30 healthy subjects. The 
diagnosis was confirmed with histopathologic examinations of biopsy 
specimens in 17 patients. He concluded that there was a significant 
difference (p < 0.05) between the control group and the patient group 
with respect to the presence of abnormal (type I + type II) Doppler 
waveform. The diagnostic accuracy in the patients who had biopsy was 
76.47% and that in the patients who did not was 69.23%. 
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     So, the Monophasic waveform implies the severity of the disease 
when compared to Biphasic waveform.  
     In those 60 Patients 35% were Clinically Diagonised as Alcoholic 
Liver Disease, 10% were DCLD, 8% were EHPVO, 25% were Portal 
Hypertension and 22% were Viral Hepatits. 
          All the patients were given Propranolol (PPNL). And followup 
Hepatic venous waveform taken every 15 days. No patients showed 
improvement in 15 days. Most of the patients showed improvement in 1 
Month.  
     Thirty Nine Out of Forty Two Patients showed improvement in the 
Hepatic venous waveform. And this correlates with the clinical 
improvement. ie 92.8% patients showed improvement after PPNL both 
clinically and Dopplerwise. 
     Soon Koo Baik et al. prospectively evaluated both the correlation 
between abnormal Doppler ultrasonography (US) hepatic vein 
waveforms and the hepatic venous pressure gradient (HVPG) and the 
response to drug treatment in patients with cirrhosis. And he concluded 
that Doppler US hepatic vein waveform assessment is useful in the 
noninvasive evaluation of the severity of portal hypertension and the 
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response to vasoactive drugs (terlipressin) in patients with portal 
hypertension and variceal bleeding. 
     A change in hepatic vein waveform seems to be closely associated 
with a change in HVPG. Hence, these results indicate that the evaluation 
of hepatic vein Doppler waveform could be a valuable supplemental tool 
when assessing the therapeutic response to vasoactive drugs used to treat 
portal hypertension when HVPG measurement is unfeasible or 
unavailable. For instance, if a monophasic waveform transformed into a 
biphasic or triphasic waveform after administration of ß-blockers, one 
might presume that the ß-blockers reduced the portal pressure. 
     The exact cause of changes in the hepatic vein Doppler waveform 
remains unclear. Some investigators have suggested that the hepatic vein 
wall is thin and surrounded by liver parenchyma so that its compliance 
can be easily reduced by parenchymal fibrosis and fat infiltration. 
However, the terlipressin-induced improvement in the waveforms 
suggests that a hemodynamic effect of high portal pressure rather than a 
fixed structural abnormality is the pathogenic mechanism responsible 
for the abnormal waveforms. We believe that high portal pressure 
probably contributes to the flattening of the normal triphasic hepatic 
vein waveform by hemodynamically blunting the effect of variations in 
central venous pressure during the cardiac cycle. 
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     In our study Hepatic venous forms were not correlated with Hepatic 
venous pressure gradient (HVPG) which is an invasive procedure.  So 
many studies concluded that there was a strong correlation between the 
severity of portal hypertension and dampening of hepatic venous 
waveform in Doppler ultra sound. 
     Our study showed 70% of abnormal HV waveforms in clinically 
diagnosed portal hypertension patients.    
     In those abnormal waveform patients 71% showed Biphasic.  39% 
showed Monophasic (Baseline observations).  After PPNL all those 
Biphasic patients showed triphasic waveforms.  In those Monophasic 
waveform patients 75% showed improvement either to Biphasic or 
Triphasic. 25% of Baseline Monophasic patients showed no 
improvement even after two months followup. 
     Our study had some limitations. This is a single observer study. And 
the findings were not correlated with HVPG.  There was a 
preponderance of men in our study. This was unavoidable, and it reflects 
the fact that cirrhosis due to alcohol, viral hepatitis, or both, is more 
prevalent in Indian men.   
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SUMMARY 
     A prospective study of 60 patients with clinical diagnosis of portal 
hypertension referred from in and out patient department of Surgery and 
Gastroenterology was done in the Barnard Institute of Radiology, 
Madras Medical College. Male to Female ratio was 2 : 1.  The patients 
belonged to age group ranging from 22 to 62 years.  Patients were then 
evaluated using Duplex-Doppler Ultrasound with the 3.5 MHz 
curvilinear transducer. 
     This study takes into account a single variable (Hepatic Venous 
waveform Pattern) to detect the response to vasoactive drug (PPNL) in 
patients with clinical diagnosis of portal hypertension. It is not 
correlated with HPVG.   
     Our study showed a strong correlation between the severity of the 
disease and dampening of hepatic venous waveform in spectral Doppler.  
92.8% of patients showed improvement of baseline waveform and this 
correlates with the clinical improvement.   
     So, Doppler ultra sound evaluation of hepatic venous waveform 
pattern (Qualitative) can be used to assess the severity of portal 
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hypertension and to monitor the response to vasoactive drug (PPNL).   It 
can be a useful non invasive tool in portal hypertension evaluation and is 
an alternative to HPVG. 
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CONCLUSION 
      Classification of the hepatic vein Doppler waveform seems to be 
superior to any quantitative Doppler indices in terms of reproducibility, 
technical ease of use, and accuracy. Indeed, the method used for 
qualitative evaluation of hepatic vein Doppler waveforms is simple 
enough to potentially allow widespread clinical use. 
      In our study thirty nine out of forty two Patients showed 
improvement in the Hepatic venous waveform after PPNL. And this 
correlates with the clinical improvement. i.e. 92.8% patients showed 
improvement after PPNL both clinically and Doppler wise. 
     In conclusion, assessment of the hepatic vein waveform with Doppler 
US could be considered a useful adjunctive method in the noninvasive 
assessment of the severity of portal hypertension and the response to 
vasoactive drugs in patients with portal hypertension and variceal 
bleeding. 
 
 
BIBLIOGRAPHY 
 
• 1. Ohta M, Tomikawa M, Ueno K, Tanoue K, Sugimachi K. 
Analysis of hepatic vein waveform by Doppler ultrasonography in 
100 patients with portal hypertension. PMID: 8304297. 
• 2. Hepatic vein Doppler waveform changes in early stage  
(Child-Pugh A) chronic parenchymal liver disease Journal of 
Clinical Ultrasound Volume 25, Issue 1, Pages 15 – 19. 
• 3. Doppler waveform of the hepatic veins in an obese population 
European Radiology, Volume 14, Number 12 / December, 2004, 
Pages 2268-2272. 
• 4. Hepatic vein Doppler waveform in patients with diffuse fatty 
infiltration of the liver doi:10.1016/j.ejrad.2004.05.011.   
• 5. S. Jequier, J. C. Jequier, S. Hanquinet, J. Gong, C. Le Coultre 
and D. C. Belli Doppler Waveform of Hepatic Veins in Healthy 
Children, AJR 2000; 175:85-90. 
 
• 6. Hashizume M. Prognostic significance of hepatic vein 
waveform by Doppler ultrasonography in cirrhotic patients with 
portal hypertension. Am. j. gastroenterol.  ISSN 0002-9270. 1995, 
vol. 90, no10, pp. 1853-1857 (24 ref.) 
• 7. W Gorka, A al Mulla, M al Sebayel, I Altraif and TS Gorka 
Qualitative hepatic venous Doppler sonography versus portal 
flowmetry in predicting the severity of esophageal varices in 
hepatitis C cirrhosis American Journal of Roentgenology, Vol 169, 
511-515 
• 8. H. Sugimoto ,M. Hirota, S. Kure, N. Kanazumi, S. Nomoto, S. 
Inoue, S. Takedaa, T. Kiuchia and A. Nakaoa Normal Hepatic 
Hemodynamics During Early Postoperative Period in Recipients 
With Adult Live Donor Liver Transplantation Proceedings  
Volume 39, Issue 1, January-February 2007, Pages 160-165   
• 9. Soon Koo Baik. Recent Variceal Bleeding: Doppler US 
Hepatic Vein Waveform in Assessment of Severity of Portal 
Hypertension and Vasoactive Drug Response.  (RSNA)Radiology 
2006;240:574-580 
 
• 10. Moon Young Kim. Damping index of Doppler hepatic vein 
waveform to assess the severity of portal hypertension and 
response to propranolol in liver cirrhosis: a prospective 
nonrandomized study.  Liver International Volume 27 Issue 8 
Page 1103-1110, October 2007 
• 11. J F PEDERSEN, Abnormal hepatic vein Doppler waveform in 
patients without liver disease.  The British Journal of Radiology, 
March 2005 
• 12. KC Sudhamshu, Doppler study of hepatic vein in cirrhotic 
patients: Correlation with liver dysfunction and hepatic 
hemodynamics. World J Gastroenterol 2006 September 28; 
12(36): 5853-5858, World Journal of Gastroenterology ISSN 
1007-9327 
 
PROFORMA 
 
 
Hepatic Venous Waveform Pattern In Cirrhosis Before And After 
Propanolol 
 
1. Name     : 
 
2. Age/Sex     : 
 
3. Address     : 
 
4. Present Complaint   : 
 
5. Relevant H/O    : 
             Jaundice 
o Hematemesis 
o Malena 
o Abdominal Distension 
 
6. Clinical Examination   : 
 
o Anaemia, 
o Pulse Rate 
o Blood Pressure 
o Jaundice 
o Flapping Tremor 
 
7. Investigations    : 
o Hb% 
o Sr.Bilirubin  
o Sr.Hb S Ag 
o Usg Abdomen 
 
8. Treatment H/O    : 
 
9. Portal Doppler (Before PPNL) : 
o Portal Vein - Size, PSV, Direction Of Flow, Phasic 
Variation 
o Hepatic Vein - Wave Form 
o Splenic Vein - Size, PSV, Direction Of Flow 
 
10.  Follow Up HV Waveform  : 
        11.  Response To PPNL   :        
 ABBREVIATIONS 
 
 DCLD  -  decompensted liver disease 
 EHPVO  - extra hepatic portal vein obstruction 
 F   -  female 
 HV   -  hepatic vein 
 HVPG - hepatic venous pressure gradient 
 M   -  male 
 PPNL  -  propranolol 
 PV   - portal vein 
 US  - ultrasonography 
  
  
 
 
